15% of severe forms of the disease can be attributed to genetic and immunological anomalies.
Under the scientific leadership of Gilles Saint-Paul (PSE, ENS) and the executive leadership of Axelle Ferrière (PSE, CNRS), the SCOR-PSE Chair, created in June...